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Several forms of monogenic heritable autism spectrum disorders
are associated with mutations in the neuroligin genes. The
autism-linked substitution R451C in neuroligin3 induces local
misfolding of its extracellular domain, causing partial retention in
the ER (endoplasmic reticulum) of expressing cells. We have
generated a PC12 Tet-On cell model system with inducible
expression of wild-type or R451C neuroligin3 to investigate
whether there is activation of the UPR (unfolded protein response)
as a result of misfolded protein retention. As a positive control
for protein misfolding, we also expressed the mutant G221R
neuroligin3, which is known to be completely retained within
the ER. Our data show that overexpression of either R451C
or G221R mutant proteins leads to the activation of all three
signalling branches of the UPR downstream of the stress sensors
ATF6 (activating transcription factor 6), IRE1 (inositol-requiring
enzyme 1) and PERK [PKR (dsRNA-dependent protein kinase)-
like endoplasmic reticulum kinase]. Each branch displayed
different activation profiles that partially correlated with the
degree of misfolding caused by each mutation. We also show
that up-regulation of BiP (immunoglobulin heavy-chain-binding
protein) and CHOP [C/EBP (CCAAT/enhancer-binding protein)-
homologous protein] was induced by both mutant proteins but
not by wild-type neuroligin3, both in proliferative cells and cells
differentiated to a neuron-like phenotype. Collectively, our data
show that mutant R451C neuroligin3 activates the UPR in a novel
cell model system, suggesting that this cellular response may have
a role in monogenic forms of autism characterized by misfolding
mutations.
Key words: autism, ER stress, molecular chaperones, neuroligin,
protein misfolding, unfolded protein response.
INTRODUCTION
Genetic studies of monogenic forms of ASDs (autism spectrum
disorders) have identified synaptic function as one of the
molecular pathways underlying neurodevelopmental disorders
[1]. Among the most studied susceptibility genes are the
neuroligins (NLGNs), postsynaptic cell adhesion proteins
involved in the maturation, specification and plasticity of neuronal
networks through the interaction with presynaptic neurexins [2].
Rare human autism-linked mutations in the NLGN genes have
been shown to affect protein folding and trafficking to the cell
surface.
The R451C single point mutation in NLGN3, an X-linked
gene, was found in association with highly penetrant autism in
a Swedish family [3]. The R451C NLGN3 protein has been
extensively characterized in overexpression studies in several
systems [4–7]. Partial retention in the ER (endoplasmic reticulum)
of the R451C mutant protein resulted from local misfolding of
the extracellular domain of NLGN3. Whereas most of the mutant
protein was degraded, a small fraction of the protein was correctly
trafficked to the cell surface [8]. Consistent with these in vitro
studies, in vivo work on knockin R451C NLGN3 mice has shown
that this mutation caused a 90% reduction in NLGN3 protein
levels [9].
A group of diseases called ERSDs (ER storage diseases)
includes disorders characterized by protein misfolding and its
recognition by the ER quality control system [10]. For these
disorders, the pathological phenotype may be due to ER retention
of excess misfolded protein and/or to the lack of functional protein
at the final destination. ERSDs are characterized by the presence
of ER stress due to protein overload, and by the activation of
an adaptive and protective response called the UPR (unfolded
protein response), finalized to restore normal ER function [11,12].
ER stress triggers the UPR through three sensors present in the
ER membrane: IRE1 (inositol-requiring enzyme 1), PERK [PKR
(dsRNA-dependent protein kinase)-like endoplasmic reticulum
kinase] and ATF6 (activating transcription factor 6), which are
normally maintained in the inactive conformation by association
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Figure 1 Structure and time course of expression of NLGN3 in inducible PC12 Tet-On clones
(A) Upper panel: overlay of the three dimensional structure of the α/β-hydrolase domain of NLGN4 (blue, PDB code 3BE8) and the homology model of the cholinesterase-like domain of Tg (grey), with
the location of the R451C (orange) and G221R (magenta) mutations. Overlay was obtained using the program PyMOL (http://www.pymol.org). The Swiss Model Server (http://swissmodel.expasy.org/)
was used to obtain structural template for the cholinesterase-like domain of Tg (residue 2192 to residue 2719). Lower panel: magnification of the homologous region between NLGN4 and Tg where
G221R/G2300R are located. Sequence alignment shows that the glycine residue is highly conserved in NLGN3 and Tg. (B) NLGN3 expression in PC12 cells after DOX treatment (0–72 h). WT lysates
at 48 h from DOX were used as a reference for migration and band intensity across the three panels. Molecular masses are indicated in kDa.
to the molecular chaperone BiP (immunoglobulin heavy-chain-
binding protein) [13]. Downstream targets of the UPR include
genes encoding chaperones, molecules involved in ERAD (ER-
associated degradation), membrane remodelling and protein
trafficking [14].
The goal of the present study was to understand whether the
autism-associated R451C NLGN3 protein elicits ER stress and
UPR activation in mammalian cells. We undertook a detailed
characterization of the three UPR signalling branches in a
new model system consisting in PC12 Tet-On cells with stable
and inducible expression of WT (wild-type), R451C or G221R
NLGN3. The G221R substitution in NLGN3 has been used as
a positive control because it was shown previously to severely
disrupt the folding of the extracellular domain of NLGN3 and
to cause a virtually complete retention of the protein within
the ER [8]. Although this mutation has not been described
in NLGN3, the G2300R substitution in thyroglobulin (Tg) is
associated with hypothyroidism, and causes defective intracellular
protein transport and retention within the ER [15]. The affected
Gly2300 of Tg is homologous with Gly221 in NLGN3, and is
conserved in both proteins across different species, mapping to
the core of the α/β-hydrolase domain of the NLGNs that is
structurally similar to the C-terminal portion of the Tg protein [16]
(Figure 1A).
Our data provide strong evidence that retention of NLGN3
caused by the R451C and G221R mutations induces the activation
of the UPR, albeit with different intensities and timing profiles that
partially correlate with the degree of misfolding caused by each
mutation on NLGN3. We show that all three ER stress sensors,
ATF6, IRE1 and PERK, are activated by the mutant R451C
NLGN3 protein, eliciting the corresponding signalling cascades in
a time-dependent manner upon NLGN3 synthesis. Up-regulation
of BiP and CHOP [C/EBP (CCAAT/enhancer-binding protein)-
homologous protein] was detected in both undifferentiated
and differentiated PC12 cells, supporting the hypothesis that
ER stress and UPR signalling induced by misfolded proteins
might influence neuronal functioning in individuals carrying the
mutation.
MATERIALS AND METHODS
Reagents and antibodies
Reagents, buffers, culture media and serum for cell cultures were
from Sigma–Aldrich unless stated otherwise.
The following commercial antibodies were used: anti-NLGN
pan-mouse monoclonal antibody (clone 4F9, catalogue number
129-011, Synaptic Systems), anti-p-eIF2α (eukaryotic initiation
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factor 2α) (Ser51) rabbit antibody (119A11, Cell Signaling Tech-
nology), anti-eIF2α total mouse antibody (L57A5, Cell Signaling
Technology), anti-BiP rabbit polyclonal antibody (ab53068,
Abcam), anti-CHOP mouse monoclonal antibody (ab11419,
Abcam), rabbit polyclonal anti-GAPDH (glyceraldehyde-3-
phosphate dehydrogenase) (ab37168, Abcam), goat polyclonal
anti-lamin A/C (N18, Santa Cruz Biotechnology), mouse
monoclonal anti-KDEL (ADI-SPA-827, Enzo Life Sciences),
mouse βIII-tubulin (MMS-435P, Covance), rabbit anti-FLAG
(F7425, Sigma), mouse anti-FLAG M2 monoclonal antibody
(F3165, Sigma) and rabbit anti-calnexin polyclonal antibody
(SPA-860, Enzo Life Sciences). Goat secondary anti-rabbit IgG
(rhodamine-conjugated) and anti-mouse IgG (FITC-conjugated)
were from Abcam.
Plasmid construction
pTRE tight Tet-On containing the N-terminal FLAG-tagged full-
length rat NLGN3 cDNA was created by inserting the NLGN3
cDNA extracted from pcDNA3.1-NLGN3 [4] in the Tet-On pTRE
tight vector (Clontech). The luciferase reporter constructs used
were the following: (5×)ATF6-luc (firefly) encoding five tandem
copies of the ATF6 consensus binding sites upstream of the
luciferase gene; and the pRL-TK (Renilla), which drives Renilla
luciferase constitutive expression as a reporter for transfection
efficiency. Both luciferase constructs were originally from Dr
Timothy Weaver (Cincinnati Children’s Hospital Medical Center,
Cincinnati, OH, U.S.A.) [17].
Culture of stable PC12 Tet-On cells
PC12 Tet-On cells were cultured following the supplier’s
guidelines (Clontech). Briefly, cells were cultured in DMEM
(Dulbecco’s modified Eagle’s medium) supplemented with 10%
(v/v) horse serum, 5% (v/v) Tet-approved FBS (BD Biosciences),
10 mM Hepes (PAA), 1× GlutaMAXTM (Gibco), 0.2 unit/ml
bovine insulin, 200 μg/ml Geneticin®, 150 μg/ml hygromycin
B (Life Technologies).
PC12 Tet-On cells were differentiated into neurons by plating
on to glass coverslips pre-treated with 0.1 mg/ml poly-L-lysine
and 0.1 mg/ml rat tail collagen I, and culturing in DMEM
supplemented with 1% (v/v) horse serum, non-essential amino
acids, Hepes, 0.2 unit/ml bovine insulin, 200 μg/ml Geneticin®,
150 μg/ml hygromycin B and 150 ng/ml NGF (nerve growth
factor) for 5 days. Tunicamycin treatments of PC12 Tet-On
parental cells, used as positive control for UPR activation, was
performed for 16 h at 2 μg/ml. Thapsigargin was used at 500 nM
for 16 h.
Generation and characterization of stable PC12 Tet-On cell lines
expressing NLGN3
PC12 NLGN3 Tet-On clones were generated by co-
transfecting pTRE response plasmid encoding NLGN3 and pTK-
Hyg resistance vector, using the LipofectamineTM procedure
(Life Technologies). Transfected cells were cultured in a
selective medium containing 150 μg/ml hygromycin B and
200 μg/ml Geneticin®. Isolated clones were screened for
NLGN3 expression by Western blot analysis after NLGN3
expression was induced with doxycycline (DOX). NLGN3
expression was typically induced with 1 μg/ml DOX. The
MG132 proteasome inhibitor was added in the medium
for the last 16 or 24 h of culture, depending on the
experimental procedures at concentrations ranging from 0.1 to
1 μM. GSK2606414 (Selleck Chemicals) treatment (50 nM for
60 min) was used to evaluate PERK-mediated phosphorylation
of eIF2α.
Preparation of PC12 Tet-On cell extracts
Lysates of PC12 cells were prepared using lysis buffer (150 mM
NaCl, 10 mM Tris/HCl, pH 8.0, and 0.5% Nonidet P40)
supplemented with protease inhibitor cocktail. Detection of
eIF2α phosphorylation required a lysis buffer with phosphatase
inhibitors (10 mM tetrasodium pyrophosphate, 15.5 mM 2-
glycerophosphate and 100 mM NaF). Lysis was performed
for 15 min on ice, and the soluble fraction was cleared by
centrifugation at 17000 g for 15 min at 4 ◦C.
Nuclear fraction enrichment
The cytosolic fraction was isolated by incubating the cells on
ice for 10 min with low-salt lysis buffer (10 mM Hepes, pH 7.4,
42 mM KCl, 5 mM MgCl2, 1 mM DTT, 0.5% Nonidet P40
and protease inhibitor cocktail) followed by centrifugation at
17000 g for 10 min at 4 ◦C. The supernatant was collected,
whereas for nuclear fraction enrichment, the insoluble pellet was
further incubated on ice for 30 min with high-salt buffer (50 mM
Tris/HCl, pH 7.5, 400 mM NaCl, 1 mM EDTA, 1% Triton X-
100, 0.5% Nonidet P40, 10% glycerol, 2 mM DTT and protease
inhibitor cocktail), followed by centrifugation at 17000 g for
10 min at 4 ◦C. The supernatant fraction was used to detect CHOP
and lamin A/C in the nuclei.
SDS/PAGE and Western blotting
Standard techniques for protein analysis included protein
quantification using the Bradford assay, protein separation by
SDS/PAGE (10% gels) (Bio-Rad Laboratories) in running
buffer (25 mM Tris/HCl, 20 mM glycine and 3.5 mM SDS)
and transfer on to Immobilon P membranes (Millipore) with
transfer buffer [25 mM Tris/HCl, 20 mM glycine and 10% (v/v)
methanol]. Membranes were blocked with 5% (w/v) non-fat
dried skimmed milk powder in T-TBS (20 mM Tris/HCl, pH 7.6,
137 mM NaCl and 0.2% Tween 20). Blocking solution for
detecting eIF2α phosphorylation was 3% (w/v) BSA in PBS.
All primary antibodies were used at a 1:1000 dilution in PBS
containing 3% (w/v) BSA. Secondary antibodies were diluted in
5% (w/v) non-fat dried skimmed milk powder in T-TBS: HRP
(horseradish peroxidase)-conjugated anti-mouse and anti-rabbit
were diluted 1:10000 and HRP-conjugated anti-goat was diluted
1:50000. The HRP signal was developed using the LiteAblot
PLUS and TURBO extra sensitive chemoluminescent substrates
(Euroclone) and exposed to autoradiographic films (Santa Cruz
Biotechnology) or revealed by using the ChemiDocTM MP
System (Bio-Rad Laboratories). Densitometry was performed
on at least three independent experiments using ImageJ software
(NIH).
Endoglycosidase H digestion
Cell extracts from PC12 NLGN3 Tet-On cells induced for 24 h by
DOX were denatured for 10 min using a commercial buffer (New
England Biolabs). EndoH (endoglycosidase H) (New England
Biolabs) digestion employed 1500 enzymatic units in the provided
reaction buffer at 37 ◦C for 3 h. Digested proteins were subjected
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Figure 2 Localization and degradation of NLGN3 in inducible PC12 Tet-On clones
(A) EndoH treatment of lysates from cells expressing WT, R451C and G221R NLGN3. The image presents different parts of the same Western blot. (B) NLGN3 localization in PC12 cells differentiated for
5 days with NGF. WT NLGN3 (FLAG, red) did not show any co-localization with calnexin (green), in contrast with the R451C and G221R mutant proteins showing partial and complete co-localization
(yellow). DAPI (blue) was used to stain the nuclei. (C) Left panels: Western blot analysis of NLGN3 protein levels after 48 h of DOX treatment and 24 h of MG132 (0.1, 0.5 and 1μM). GAPDH was
used as loading control. Histograms on the right show NLGN3/GAPDH densitometric analysis normalized to WT NLGN3 levels in the absence of MG132. Statistical analysis comparing treated and
untreated conditions within each clone (n = 4; **P < 0.01, ***P < 0.001). Molecular masses are indicated on the blots in kDa.
to SDS/PAGE and immunoblotting using the commercial anti-
NLGN antibody.
Immunocytochemistry
PC12 Tet-On cells expressing either WT or mutant NLGN3
proteins were plated on glass coverslips coated with 0.1 μg/ml
poly-L-lysine and grown in DMEM. Cells were fixed in
4% (w/v) paraformaldehyde in PBS, washed and incubated
with blocking buffer (PBS, 2% normal goat serum, 0.5%
BSA and 50 mM glycine) [4]. Primary antibody incubation
was performed with either rabbit anti-FLAG or anti-
FLAG M2 mouse monoclonal antibody diluted 1:500 in
combination with the anti-calnexin or anti-CHOP diluted
1:200 in 5× diluted blocking buffer. Secondary antibodies were
diluted 1:500 in the same buffer. Nuclei were stained with
DAPI.
Four or five images for each sample were captured at room
temperature using a Nikon inverted confocal microscope with
×40 and ×63 objective lenses and processed using ImageJ and
Adobe Photoshop software.
Real-time RT (reverse transcription)–PCR
Total RNA was extracted from PC12 NLGN3 Tet-On cells
by using TRIzol® reagent (Life Technologies) following the
manufacturer’s procedures. First-strand cDNA was synthesized
using Superscript II (Life Technologies) starting from 4 μg
of RNA following the manufacturer’s recommended protocols.
cDNA was amplified by using SYBR Green (Life Technologies)
and the Applied Biosystems suggested protocol consisting of 40
cycles of amplification with each cycle including 15 s at 95 ◦C
followed by 60 s at 60 ◦C. Real-time RT–PCR was carried out
using a thermocycler iCycler PCR Detection System (Bio-Rad
Laboratories) and individual melting curves were produced to
assess the specificity of each primer set. All assays were run
in triplicate and relative quantification was calculated using the
comparative CT method [18].
Used primer sets were: BiP forward 5′-TACTCGAATT-
CCAAAGATTCAG and reverse 5′-TCAAGCAGAACCAG-
GTC; XBP1s forward 5′-ATGGATGCCCTGGTTGCTGAA
and reverse 5′-CCTGCACCTGCTGCGGACT; 18s forward
5′-ACGGACCAGAGCGAAAGCAT-3′ and reverse 5′-TGT-
CAATCCTGTCCGTGTCC-3′; GAPDH forward 5′-GTGCCA-
GCCTCGTCTCATAG-3′ and reverse 5′-TGATGGCAACAA-
TGTCCACT-3′.
Luciferase assay
PC12 NLGN3 Tet-On clones were seeded on 0.1 mg/ml poly-L-
lysine pre-coated six-well plates. At 24 h after plating, NLGN3
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Figure 3 Activation of the UPR transcriptional factors
(A) PC12 cells were transfected with the luciferase reporter vectors after inducing NLGN3 synthesis with DOX (from 0 to 72 h). For each clone, the ratio of firefly/Renilla luciferase was normalized
to the − DOX condition at each of the time points. Results are means +− S.E.M. for six independent experiments. Mutants compared with WT values, for all time points: ***P < 0.001, except for
R451C at 48 h, *P < 0.05 and 72 h, **P < 0.01. R451C compared with G221R at 24 h and 48 h: **P < 0.01. (B) NLGN3 synthesis was induced for 48 h with DOX and 0.5 μM MG132 was added
for the last 24 h. Results are means +− S.E.M. for five independent experiments (***P < 0.001 and **P < 0.01). (C) NLGN3 synthesis was induced, from 0 to 48 h, and the splicing of XBP1 was
quantified by real-time RT–PCR. Changes in XBP1s were calculated relative to the 18S housekeeping gene and normalized to the − DOX condition. For each time point, statistical relevance of four
independent experiments was calculated comparing NLGN3 mutants with WT. A peak value of XBP1s was observed at 16 h from DOX induction in the R451C NLGN3 cells (R451C compared with
WT, ***P < 0.001; R451C compared with G221R, **P < 0.01), whereas G221R NLGN3 overexpression caused a slower but steady XBP1 splicing increase (*P < 0.05 at 24 h and **P < 0.01 at
48 h). XBP1 splicing in WT NLGN3 cells was unchanged over time. (D) NLGN3 protein levels were quantified after DOX induction of NLGN3 synthesis for 16 h in the presence or absence of MG132
(0.5 μM). The Western blot is representative of four independent experiments. Molecular masses are indicated in kDa.
expression was induced for several lengths of time (0, 12,
16, 24, 48 and 72 h) and transfection with LipofectamineTM
2000 occurred for the last 24 h using 2 μg of total DNA:
pATF6(5×)-Luc (firefly) and PRL-TK (Renilla) in a 50:1 ratio.
Lysis buffer provided by the Dual-Luciferase Reporter Assay
(Promega) was used for harvesting the cells and the substrates
included in the kit were used for determining firefly and
Renilla luciferase activities. A GloMax multi + detection system
(Promega), with injectors for substrate addition, was used for
detecting the luminescence signals. The luciferase activity was
calculated as a ratio of the firefly to Renilla value relative to
the − DOX condition. All measurements were carried out in
triplicate.
Statistical analysis
All the experiments were performed at least three times on
independent samples.
For all experiments, one-way ANOVA followed by
Bonferroni’s post-hoc test were used for statistical analysis
with Prism5 (GraphPad Software): *P < 0.05, **P < 0.01,
***P < 0.001; ns, non-significant.
RESULTS
R451C and G221R NLGN3 are retained within the ER and degraded
by ERAD in a novel PC12 cell model system
Time-dependent activation of the UPR was studied in the rat
phaeochromocytoma PC12 cell line, modified with the Tet-
On gene regulatory system. This line was chosen because it
can be differentiated into a neuronal-like phenotype by NGF
treatment [19]. PC12 Tet-On NLGN3 cell lines were generated
by transfecting PC12 cells with the DOX-inducible pTRE-tight
vector containing the FLAG-tagged cDNAs encoding WT, R451C
or G221R NLGN3.
Stably transfected PC12 clones expressing NLGN3 were
screened for DOX-induced NLGN3 synthesis. Clones grown in
the absence of DOX were used to assess the stringency of the
Tet-On expression system. In addition to the WT protein and the
R451C mutant variant that causes autism, we have also created
a PC12 G221R NLGN3 line as a positive control for protein
misfolding. This mutation introduces a bulky arginine side chain
in the core of the α/β-hydrolase domain (Figure 1A), leading
to complete misfolding of the extracellular domain of NLGN3,
as indicated by previous studies based on the use of trypsin
proteolysis [8].
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Figure 4 PERK branch activation
(A) Upper panel: time course densitometric analysis of Western blot for p-eIF2α, from 0
to 48 h from DOX treatment, normalized to total eIF2α levels. Significant differences were
observed for R451C and G221R NLGN3 mutant clones at 12 h from DOX treatment (**P < 0.01
and ***P < 0.001 respectively) in comparison with WT. Mean+−S.E.M. values were from
four independent experiments. Lower panel: representative Western blot for p-eIF2α and
total eIF2α from PC12 NLGN3 Tet-On cells at 12 h after DOX administration. Molecular
masses are indicated in kDa. (B) Densitometry of p-eIF2α normalized to total eIF2α from
four independent experiments on PC12 cells at 12 h from DOX induction, without or with
50 nM GSK2606414 treatment. Mean+−S.E.M. values were from four independent experiments
(*P < 0.05, **P < 0.01, ***P < 0.001).
Three representative clones were chosen for each NLGN3
variant (WT, R451C-2 and G221R-1, Supplementary Figures S1A
and S1B), based on NLGN3 protein and mRNA levels. We named
the new cell lines WT, R451C and G221R NLGN3. Western
blot analysis of the cell lysates was used to investigate the time-
dependent expression of NLGN3 in these lines (Figure 1B and
Supplementary Figure S1C). In cells expressing WT NLGN3, we
detected the presence of a single ∼110 kDa band. In contrast,
R451C NLGN3 protein presented as two bands with apparent
molecular masses ranging from ∼100 kDa to ∼110 kDa. G221R
NLGN3 appeared as a single band of ∼100 kDa (Figure 1B and
Supplementary Figure S1C). We then used sensitivity to EndoH
to detect the presence of immature high-mannose N-glycans
typical of proteins retained in the ER and to characterize the
bands observed by Western blotting (Figure 2A). As expected,
WT NLGN3 was resistant to enzymatic digestion, as indicated
by the absence of a band shift upon EndoH treatment. In
contrast, the faster migrating band of R451C NLGN3 showed
a band shift after digestion, revealing its immature nature. G221R
NLGN3 mutant protein showed a complete digestion to a lower
deglycosylated band (Figure 2A) in agreement with the complete
retention of this mutant protein in the ER [8]. To confirm
that the mutant proteins were retained in the ER, we used
immunofluorescence co-localization analysis with the ER marker
calnexin. WT NLGN3 localized to the cell membrane, whereas
R451C NLGN3 showed partial ER retention and G221R showed
complete co-localization with calnexin, supporting our previous
observations [7] (Figure 2B).
To ascertain whether the involvement of ERAD might explain
the lower levels of protein seen at steady state for the R451C
and G221R mutants in comparison with WT NLGN3, we treated
the cells with different concentrations of the proteasome inhibitor
MG132 (Figure 2C). A significant increase in the levels of the
mutant variants of NLGN3 was observed after MG132 treatment
(0.5 μM and 1 μM), whereas WT NLGN3 levels remained
unaltered. Consistent with our previous findings [8], this indicates
that the mutant proteins were degraded by ERAD.
Mutant R451C and G221R NLGN3 activate the transcriptional arm
of the UPR
The activation of each UPR branch driven by ATF6, IRE1 and
PERK was studied in our cell model, by performing time course
experiments. We first analysed the activation of the UPR by
using a reporter where luciferase expression is driven by ERSEs
(ER stress elements) based on those found in the promoters of
ATF6 target genes [pATF6(5×)-Luc] [17]. We co-transfected the
PC12 NLGN3 cells with the pATF6(5×)-Luc reporter and the
transfection control pKT-Renilla at different times after DOX
administration (0, 12, 16, 24, 48 and 72 h). Both mutant variants
of NLGN3 induced the highest luciferase signal between 12 and
24 h, significantly above the values obtained for the WT NLGN3
cells (Figure 3A). For the mutant proteins, the activation of the
reporter remained stable during prolonged NLGN3 synthesis and
was significantly different from the WT. The highest levels of
ATF6 activation were achieved by the G221R mutant from 24 to
72 h. Because the R451C and G221R mutations increase NLGN3
degradation through ERAD (Figure 2C), we also analysed the
activation of this reporter after blocking the proteasome with
MG132. A significant increase in signalling was observed only
in R451C and G221R NLGN3-expressing cells, but not in WT
NLGN3 cells (Figure 3B). These results indicate that R451C and
G221R NLGN3 behave as bona fide misfolded proteins and that
their retention in the ER activates the UPR.
The DNA-binding sites for ATF6 and XBP1 (X-box-binding
protein 1) share some similarity and so it is possible that the
ATF6(5×)–Luc reporter may reflect IRE1 signalling in addition to
ATF6 activation [20]. During ER stress, ATF6 traffics to the Golgi
apparatus where it is cleaved to a shorter cytoplasmic fragment
that translocates to the nucleus and acts as a transcriptional
factor. We thus attempted to study ATF6 activation directly
by immunodetection of cleaved ATF6. However, in our hands,
none of three different anti-ATF6 antibodies was successful for
examining ATF6 processing.
We next investigated the specific activation of IRE1. This
ER stress sensor initiates the unconventional splicing of XBP1
mRNA generating the spliced XBP1 form (XBP1s), which is
directly involved in the transcriptional activation of UPR target
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Figure 5 Expression levels of the UPR target CHOP
(A) Nuclear and cytoplasmic fractions extracted from PC12 NLGN3 cells at 24 h after DOX administration. Upper panel: Western blot detection of CHOP. Parental PC12 cells (mock) and the − DOX
conditions were used as negative controls and tunicamycin was used as a positive control. Nuclear fraction was normalized to lamin A/C protein. The Western blot is representative of four independent
experiments. Lower panel: NLGN3 detection in the cytoplasmic protein fraction. GAPDH was used as a loading control. Image presents two different parts of the same Western blot. Molecular masses
are indicated in kDa. (B) Differentiated PC12 NLGN3 cells stained with the anti-CHOP antibody (green) and anti-FLAG for detection of NLGN3 (red). Tunicamycin-treated parental PC12 cells were
used as a positive control (lower panel).
genes, such as ERAD components [21]. We quantified the levels
of XBP1s mRNA to evaluate IRE1 activation in our PC12 cell
lines after inducing NLGN3 synthesis for specific times (0, 16,
24 and 48 h) (Figure 3C). Real-time RT–PCR revealed time-
dependent changes in the levels of XBP1s for the R451C and
G221R NLGN3-expressing cells, relative to the condition where
NLGN3 synthesis was not induced ( − DOX), whereas WT
NLGN3 synthesis did not cause significant changes in XBP1s
levels at any of the times investigated (Figure 3C). The trend of
XBP1 splicing appeared different between the two mutants: the
R451C mutant caused an early and strong increase at 16 h from
synthesis, followed by its attenuation up to 48 h. The G221R
mutant induced a slower but sustained increase in XBP1s levels
over time, with the highest levels at 24 and 48 h. Our time
course data indicate that NLGN3 protein levels were lower at
16 h than at longer times of induction (Figure 1B). We studied the
degradation of mutant NLGN3 at 16 h after DOX induction using
the proteasome inhibitor MG132. We observed a striking increase
in R451C and G221R protein levels after proteasomal inhibition
(Figure 3D), indicating that ERAD prevented the accumulation
of these mutant proteins.
Mutant R451C and G221R NLGN3 activate PERK-mediated eIF2α
phosphorylation
The phosphorylation of eIF2α integrates multiple cellular stress
pathways [22]. Regulated phosphorylation of eIF2α by the
ER stress-activated protein kinase PERK modulates protein
synthesis and couples the production of ER client proteins with
the organelle’s capacity to fold and process them [23]. Since
phosphorylation of eIF2α has been shown to occur soon after ER-
stress induction in PC12 cells [24], we studied PERK activation
upon NLGN3 synthesis after 0, 4, 8, 12, 16, 24 and 48 h.
We observed that p-eIF2α levels increased over time with a
similar trend for the R451C and G221R mutant variants, whereas
they remained unaltered for the WT protein (Figure 4A, upper
panel). The increase in p-eIF2α was detectable after 4 h from
NLGN3 induction and reached the highest peak at 12 h, with
both mutant variants reaching significantly higher levels over
the WT NLGN3 control (Figure 4A and Supplementary Figure
S2A). Although PERK mediates the phosphorylation of eIF2α
upon ER stress activation [25], other types of cellular stress can
lead to eIF2α phosphorylation by different kinases in mammalian
cells [26]. To study whether the peak of p-eIF2α was due to the
activation of PERK, we made use of the highly selective PERK
inhibitor GSK2606414 [27]. We first performed a dose–response
experiment in parental PC12 cells treated with tunicamycin and
thapsigargin to induce canonical UPR and using GSK2606414 at
different concentrations, and chose 50 nM as the best condition
to observe attenuation of eIF2α phosphorylation (Supplementary
Figure S2B). Densitometry quantification of Western blot analysis
showed that the GSK2606414 treatment significantly reduced
the signal of p-eIF2α in PC12 cells expressing the R451C and
G221R mutant proteins for 12 h after NLGN3 induction, whereas
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Figure 6 Up-regulation of the UPR target BiP
(A) NLGN3 was induced from 0 to 72 h by DOX and BiP mRNA levels were quantified. Time point values were normalized to − DOX, for each clone, and statistically compared with WT. Results are
means+−S.E.M. for four independent experiments. At 16 h from DOX, a robust increase in BiP mRNA is observed in the NLGN3 R451C (**P < 0.01) with respect to WT and is still significant at 48 h
(*P < 0.05). The G221R mutant protein caused an increase over the time becoming gradually significant from 24 to 72 h (*P < 0.05 at 24 h, **P < 0.01 at 48 h, ***P < 0.001 at 72 h). BiP mRNA
levels showed a flat trend for the WT NLGN3 clone. Comparison between R451C and G221R revealed significant differences between the two mutants at 72 h, *P < 0.05. (B) Representative time
course of BiP protein levels after DOX treatment from 0 to 72 h. Molecular masses are indicated in kDa. (C) Densitometry of BiP normalized to GAPDH levels was calculated after inducing NLGN3
synthesis for 24 h (n = 4). Statistical analysis compared the + DOX with the − DOX conditions (R451C *P < 0.05, G221R **P < 0.01).
no reduction was observed for cells expressing WT NLGN3
(Figure 4B). This supports a causal link between the retention
of the mutant NLGN3 variants in the ER and the activation of the
PERK branch of the UPR.
Expression of mutant R451C and G221R NLGN3 causes
up-regulation of UPR target genes
After finding that NLGN3 mutant proteins activated all of the
UPR stress sensors, we analysed the steady-state levels of UPR
target genes such as CHOP and BiP. Under ER stress conditions,
the transcription factor CHOP is synthesized and plays a role
in regulating ER client protein load and the redox conditions
in the organelle [28]. We found that CHOP was induced upon
expression of both NLGN3 mutant proteins, as shown by Western
blot analysis of nuclear extracts from R451C and G221R NLGN3-
expressing cells (Figure 5A, upper and lower panels), but not
in cells expressing WT NLGN3 or in cells not treated with
DOX (Figure 5A, upper panel). These results were confirmed by
immunohistochemical analysis using the same antibody against
CHOP (Figure 5B). Whereas the majority of cells overexpressing
R451C and G221R NLGN3, and the positive control cells treated
with tunicamycin, showed specific nuclear staining for CHOP,
the same was not observed in cells expressing WT NLGN3
(Figure 5B).
It is well established that induction of BiP is a marker of ER
stress and a central modulator of the UPR [29]. We thus quantified
the mRNA levels for BiP in a time course experiment ranging
from 0 to 72 h after NLGN3 protein synthesis was induced by
DOX. Although WT NLGN3 did not alter the expression of BiP
over time (Figure 6A, black circles), the synthesis of R451C
NLGN3 caused a robust increase in BiP mRNA at 16 h, followed
by a progressive attenuation at 24 and 48 h, decreasing towards
WT values at 72 h (Figure 6A, open squares). In contrast, a
slower but progressive increase was detected for G221R NLGN3
throughout the entire experimental period (Figure 6A, black
triangles).
To investigate further the effects of the NLGN3 mutant proteins
on the up-regulation of BiP, we measured its protein levels at
several times following DOX treatment. Whereas the expression
of BiP was unchanged after WT NLGN3 induction, both mutant
NLGN3 variants caused a progressive up-regulation of BiP
protein levels when compared with the uninduced condition
(Figure 6B). Interestingly, induction of G221R NLGN3 led
to an increase in BiP levels that followed the same trend
observed for its mRNA (Figure 6A). In the case of the R451C
mutant BiP protein levels remained elevated at later time
points in contrast with the levels of its mRNA (Figure 6B).
Quantification by densitometry of BiP normalized to GAPDH
levels at the 24 h time point showed a significant increase in BiP
levels in cells expressing mutant, but not WT NLGN3 proteins
(Figure 6C).
We also quantified the protein levels for Grp94 (glucose-
regulated protein of 94 kDa) and BiP in PC12 cells differentiated
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Figure 7 Levels of Grp94 and BiP in differentiated PC12 NLGN3 Tet-On clones
Upper panel: densitometry of Grp94 (left) and BiP (right) levels in mutant and WT cells treated with NGF and DOX for 72 h (n = 3). Statistical analysis compared values of the + DOX condition with
the − DOX condition (*P < 0.05, **P < 0.01, ***P < 0.001). Lower panel: representative Western blot of NGF-differentiated PC12 cells for the detection of Grp94 and BiP using the anti-KDEL
antibody. β III-Tubulin was used as a marker for differentiation and GAPDH was used as a loading control. Undifferentiated parental PC12 cells treated with tunicamycin were used as positive control.
Molecular masses are indicated in kDa.
to a neuronal phenotype by treatment with NGF and induced
for NLGN3 expression. The efficacy of the NGF treatment
was confirmed by βIII-tubulin detection, whereas levels of
both chaperones were analysed with an anti-KDEL antibody
(Figure 7, lower panel). As expected, densitometry analysis
showed a significant increase in Grp94 and BiP levels for
both R451C and G221R NLGN3-expressing cells, but not for
the control WT NLGN3 cells (Figure 7). These results are in
agreement with our previous data showing that BiP and Grp94
were the main chaperones interacting with R451C and G221R
NLGN3 [8].
DISCUSSION
A growing number of neurological genetic diseases are
characterized by the accumulation of misfolded proteins within
the ER [30]. This can lead to the perturbation of ER homoeostasis
and to the activation of the UPR, an adaptive cellular signalling
pathway that aims to restore proper functioning of the organelle
through the modulation of gene expression [31]. Several mutations
in genes coding for synaptic proteins have been identified in
ASD patients, suggesting that abnormal synaptic function is a
risk factor for neurodevelopmental disorders [32]. The current
knowledge regarding the potential link between ASDs and
ER stress is minimal and mainly based on autism-associated
mutations in CNTNAP2 [33] and the synaptic adhesion protein
CADM1 [34].
In the present study, we focused on the R451C variant of
NLGN3, which is the best characterized autism-linked mutation
in the neuroligin family. Our previous work showed that the
R451C substitution affects the local folding of the extracellular
domain, causing partial retention of the mutant protein within
the ER [8]. This misfolding results in a diminished trafficking
of the protein to the cell surface, which explains, in part, the
reduced effectiveness of R451C NLGN3 to induce clustering of
proteins at the synapse in cultured neurons [6]. We have previously
compared the R451C mutation with the G221R substitution,
which causes global misfolding and complete ER retention of
NLGN3 [8,16,35]. Moreover, a substitution homologous with
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G221R in NLGN3, the G2300R mutation in the C-terminal
region of Tg (G2300R), a domain that structurally resembles the
extracellular domain of the NLGNs, leads to UPR activation in
human and rat tissues [36].
Our newly generated PC12 Tet-On inducible model system
allowed us to study the UPR signalling in time course experiments
at early and late times after induction of NLGN3 synthesis.
Expression of either R451C or G221R mutant NLGN3 caused
activation of the transcriptional factors of the UPR over the levels
observed after overexpression of the WT protein, including the
ER stress sensor ATF6 and the spliced form of the transcription
factor XBP1. The kinetics of the UPR response evoked by each
mutant variant correlated with the impact that each mutation has
on the folding of NLGN3, supporting a direct link between the
mutant genotype and the phenotype of the cellular response. In
fact, for ATF6 and XBP1 signalling, the different trends reflect
the severe and milder effects of the G221R and R451C mutations
respectively in the folding of NLGN3 due to their position in
the protein’s structure [37], with the R451C substitution being
more superficial and the G221R one buried in the core of the
extracellular domain. The impact of these mutations on the
protein’s folding is also reflected in the different glycosylation
states of the two NLGN3 variants: whereas G221R NLGN3
undergoes a progressive accumulation of high-mannose species
in the ER over time, a small fraction of the R451C protein
completes its maturation and reaches the cell surface as an EndoH-
resistant mature glycoprotein. The existence of two fractions
of R451C NLGN3 may explain the observation of a sudden
increase in UPR signalling at 16 h that decreased with time
(48–72 h).
We also observed activation of the PERK branch of the UPR
as increased eIF2α phosphorylation at 12 h after inducing the
expression of mutant but not WT NLGN3. Since eIF2α can be
phosphorylated via different pathways of the integrated stress
response [22], the possibility existed that the phosphorylation we
observed was not triggered by PERK. Recently, a number of small
molecules have been identified for inhibiting key mediators of ER
stress signalling [38,39]. We used GSK2606414 for selectively
inhibiting PERK and showed a significant decrease in eIF2α
phosphorylation upon R451C or G221R NLGN3 overexpression,
supporting a direct involvement of PERK in the phosphorylation
of eIF2α.
Overexpression of R451C or G221R, but not WT, NLGN3 in
our PC12 cells led to synthesis of CHOP, which is not generally
expressed under physiological conditions [40]. Furthermore, we
observed a transient increase in BiP mRNA levels upon expression
of R451C and G221R NLGN3 that resulted in higher protein
levels in both undifferentiated and neuron-like differentiated PC12
cells.
The downstream effects of UPR signalling observed in our
PC12 NLGN3 cells when differentiated to a neuronal phenotype
suggests that UPR elicited by the ER retention of misfolded
R451C NLGN3 might play a role in neuronal behaviour. In
fact, although the UPR is classically linked to protein folding
stress under pathological conditions, it is becoming clear that
UPR signalling also regulates various processes, including
synaptic functions [41]. At the molecular level, subtype-selective
modulation of cell-surface receptors by CHOP has been reported
[42], and the phosphorylation of eIF2α has been associated
with synaptic plasticity, learning and memory [43,44]. Moreover,
in vivo administration of GSK2606414 has been shown to
affect memory consolidation, supporting a role for UPR and its
mediators in mediating synaptic functions [45].
In conclusion, we show that in our inducible PC12 model
system, partial misfolding caused by the R451C autism-
linked mutation in NLGN3 activated the UPR. This activation
was transient, time-dependent and partially correlated to the
severity of the structural alteration caused by this mutation.
Our data in PC12 Tet-On NLGN3 cells represent the first
detailed evidence on UPR signalling promoted by autism-linked
mutations that cause ER retention of the synaptic proteins
NLGNs.
It has been reported that a mouse expressing R451C NLGN3
as an endogenous protein exhibits social behavioural traits typical
of autism, along with neurotransmission alterations, not observed
in the NLGN3-knockout mice [9,46,47]. This gain of function
could be explained by the residual fraction of R451C NLGN3
protein that reaching the surface can interact with ligands other
than the neurexins. It has been shown that the mutant protein
that reaches the surface binds to β-neurexin1 with weaker affinity
[4], therefore it is possible that β-neurexin1 is able to associate
with other synaptic partners (e.g. LRRTM2), thus driving the
gain of function observed in the knockin mice. However, this
hypothesis does not exclude the possibility that ER stress, induced
by the fraction of mutant NLGN3 that remains within the ER,
might be an additional factor taking part in the gain-of-function
phenotype.
To gain further insight into the potential role of UPR in
neurodevelopmental disorders, it will be critical to test whether
the cellular responses observed in our cell model system also take
place in vivo, and whether the gain of function observed in mice
has its origin in these cellular events associated with ER stress.
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